Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept.

Rákóczi É, Perge B, Végh E, Csomor P, Pusztai A, Szamosi S, Bodnár N, Szántó S, Szücs G, Szekanecz Z.

Joint Bone Spine. 2016 Mar 16. pii: S1297-319X(16)00043-9. doi: 10.1016/j.jbspin.2015.10.017. [Epub ahead of print]

PMID:
26995488
2.

Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do.

Szekanecz Z, Kerekes G, Végh E, Kardos Z, Baráth Z, Tamási L, Shoenfeld Y.

Autoimmun Rev. 2016 Mar 12. pii: S1568-9972(16)30062-3. doi: 10.1016/j.autrev.2016.03.014. [Epub ahead of print] Review.

PMID:
26979271
3.

Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.

Glant TT, Ocsko T, Markovics A, Szekanecz Z, Katz RS, Rauch TA, Mikecz K.

PLoS One. 2016 Mar 4;11(3):e0150784. doi: 10.1371/journal.pone.0150784. eCollection 2016.

4.

Patients' access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences.

Gulácsi L, Rencz F, Poór G, Szekanecz Z, Brodszky V, Baji P, Péntek M.

Ann Rheum Dis. 2016 May;75(5):942-3. doi: 10.1136/annrheumdis-2015-208741. Epub 2016 Feb 17. No abstract available.

PMID:
26888946
5.

Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications.

Pallai A, Kiss B, Vereb G, Armaka M, Kollias G, Szekanecz Z, Szondy Z.

J Immunol. 2016 Feb 1;196(3):1146-57. doi: 10.4049/jimmunol.1501573. Epub 2016 Jan 4.

PMID:
26729808
6.

Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.

Rentka A, Harsfalvi J, Szucs G, Szekanecz Z, Szodoray P, Koroskenyi K, Kemeny-Beke A.

Immunol Res. 2016 Apr;64(2):619-26. doi: 10.1007/s12026-015-8763-9.

PMID:
26687127
7.

Targeting of proangiogenic signalling pathways in chronic inflammation.

Tas SW, Maracle CX, Balogh E, Szekanecz Z.

Nat Rev Rheumatol. 2016 Feb;12(2):111-22. doi: 10.1038/nrrheum.2015.164. Epub 2015 Dec 3. Review.

PMID:
26633288
8.

Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.

Szekanecz Z, Koch AE.

Nat Rev Rheumatol. 2016 Jan;12(1):5-13. doi: 10.1038/nrrheum.2015.157. Epub 2015 Nov 26. Review.

PMID:
26607389
9.

Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis.

Rentka A, Hársfalvi J, Berta A, Köröskényi K, Szekanecz Z, Szücs G, Szodoray P, Kemény-Beke Á.

Mediators Inflamm. 2015;2015:573681. doi: 10.1155/2015/573681. Epub 2015 Aug 3.

10.

Successful Treatment of CINCA/NOMID Syndrome with Interleukin-1 Blockade.

Macejová Z, Vargová V, Matejka M, Szekanecz Z.

Isr Med Assoc J. 2015 Jun;17(6):389-91. No abstract available.

11.

Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis.

Kovács A, Siminischi AG, Baksay B, Gáll A, Takács M, Szekanecz Z.

Isr Med Assoc J. 2015 Feb;17(2):114-6. No abstract available.

12.

Vitamin D status in men with psoriatic arthritis: a case-control study.

Petho Z, Kulcsar-Jakab E, Kalina E, Balogh A, Pusztai A, Gulyas K, Horvath A, Szekanecz Z, Bhattoa HP.

Osteoporos Int. 2015 Jul;26(7):1965-70. doi: 10.1007/s00198-015-3069-2. Epub 2015 Feb 19.

PMID:
25693749
13.

Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases.

Váradi C, Holló Z, Póliska S, Nagy L, Szekanecz Z, Váncsa A, Palatka K, Guttman A.

Electrophoresis. 2015 Jun;36(11-12):1330-5. doi: 10.1002/elps.201400575. Epub 2015 Apr 15.

PMID:
25639738
14.

Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.

Kurkó J, Vida A, Ocskó T, Tryniszewska B, Rauch TA, Glant TT, Szekanecz Z, Mikecz K.

PLoS One. 2014 Nov 4;9(11):e111815. doi: 10.1371/journal.pone.0111815. eCollection 2014.

15.

[Applicability of laser-based geological techniques in bone research: analysis of calcium oxide distribution in thin-cut animal bones].

Andrássy L, Maros G, Kovács IJ, Horváth Á, Gulyás K, Bertalan É, Besnyi A, Füri J, Fancsik T, Szekanecz Z, Bhattoa HP.

Orv Hetil. 2014 Nov 9;155(45):1783-93. doi: 10.1556/OH.2014.30010. Review. Hungarian.

PMID:
25362641
16.

Occurrence of pulmonary rheumatoid nodules following biological therapies.

Kovács A, Baksay B, Cserenyecz A, Molnár K, Takács M, Szekanecz Z.

Clin Rheumatol. 2015 Sep;34(9):1639-42. doi: 10.1007/s10067-014-2789-6. Epub 2014 Sep 30.

PMID:
25267563
17.

Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study.

Kurkó J, Vida A, Glant TT, Scanzello CR, Katz RS, Nair A, Szekanecz Z, Mikecz K.

BMC Musculoskelet Disord. 2014 Aug 19;15:281. doi: 10.1186/1471-2474-15-281.

18.

Rheumatoid arthritis and metabolic syndrome.

Kerekes G, Nurmohamed MT, González-Gay MA, Seres I, Paragh G, Kardos Z, Baráth Z, Tamási L, Soltész P, Szekanecz Z.

Nat Rev Rheumatol. 2014 Nov;10(11):691-6. doi: 10.1038/nrrheum.2014.121. Epub 2014 Aug 5. Review.

PMID:
25090948
19.

Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies.

Castañeda-Hernández G, Szekanecz Z, Mysler E, Azevedo VF, Guzman R, Gutierrez M, Rodríguez W, Karateev D.

Joint Bone Spine. 2014 Dec;81(6):471-7. doi: 10.1016/j.jbspin.2014.03.019. Epub 2014 Jun 20. Review.

PMID:
24956990
20.

Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study.

Laczik R, Soltesz P, Szodoray P, Szekanecz Z, Kerekes G, Paragh G, Rajnavölgyi E, Abel G, Szegedi G, Bodolay E.

Rheumatology (Oxford). 2014 Nov;53(11):2035-43. doi: 10.1093/rheumatology/keu236. Epub 2014 Jun 10.

PMID:
24917564
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk